Genomic Tests Seem to Be Better in Identifying Aggressive Prostrate Cancer | |
The traditional testing method involves clinical markers such as the PSA level or the Gleason Score. Researchers could conclude that genomic tests are better at identifying high-risk prostate cancers based on the results obtained from a group of men part of the survey. Conventional tests had declared their cancer low-risk, while the genomic test predicted that their cancer was high-risk and vulnerable to spread beyond the prostate gland. “What this [study] points us to is, beyond just the clinical markers that we’ve been using, we now have to start thinking about genomics too. I would tell patients that if they’re newly diagnosed [with prostate cancer]. They want to have a really in-depth conversation about how to get treated, they should ask their doctor if the Decipher [test] should be at least a part of their evaluation.” explains Fatima Karzai, M.D, Center for Cancer Research, NCI. For more details please visit our website - https://www.medhealthreview.com/2022/10/25/genomic-tests-seem-to-be-better-in-identifying-aggressive-prostrate-cancer/ ![]() | |
Related Link: Click here to visit item owner's website (0 hit) | |
Target State: New York Target City : New York City Last Update : Jul 30, 2025 2:03 AM Number of Views: 32 | Item Owner : medhealthreview Contact Email: Contact Phone: +1 702-213-6364 |
Friendly reminder: Click here to read some tips. |